跳至主要内容
临床试验/NL-OMON45807
NL-OMON45807尚未招募不适用

Improving quality of care for patients with recurrent ovarian cancer - MOGYN21 QoC Ovarium Carcinoma

Radboud Universitair Medisch Centrum0 个研究点目标入组 300 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 至 99(—)

入选标准

  • Patients with recurrent EOC or tubal carcinoma or peritoneal carcinoma;
  • Histologically and/or cytologically proven epithelial ovarian cancer (including carcinosarcoma of the ovaries)
  • Measurable or evaluable disease confirmed by radiological imaging OR ca 125
  • ECOG <=2
  • Estimated life expectancy >=12 weeks
  • Patients must be accessible for treatment and follow-up
  • Fit to receive chemotherapy

排除标准

  • Patients with benign ovarian cancer;
  • Patients with non-epithelial cancer;
  • Bowel obstruction, sub-occlusive disease or presence of symptomatic brain metastases;
  • Patients with other malignancy occurring within 5 years before enrollment
  • Patients with impaired cognitive functioning or analphabetic patients
  • Patients with an inability to fill in surveys digitally

研究者

相似试验

Improving quality of care for patients with... | 临床试验